ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003

NCI selects nanotech centers for funding.

October 14, 2005

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998